SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SWOG | S1706-Breast, Inflammatory, RT +/- Olaparib | 1 | Y | 1 Olaparib + RT | 300 | 74 | 11 | 7 | 3 | 3 | 1 | 01/18/2019 | 228 | 102 |
2 RT | 77 | 11 | 8 | 5 | 3 | 0 | ||||||||
151 | 22 | 15 | 8 | 6 | 1 | |||||||||
S2007-Breast, Brain Mets, Sacituzumab Govitecan | 1 | Y | 1 Sacituzumab Govitecan | 44 | 24 | 5 | 2 | 1 | 1 | 0 | 06/08/2021 | 192 | 67 | |
24 | 5 | 2 | 1 | 1 | 0 | |||||||||
S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | Y | 1 Tissue for MammaPrint testing | 960 | 34 | 34 | 34 | 29 | 15 | 4 | 11/27/2023 | 206 | 82 | |
34 | 34 | 34 | 29 | 15 | 4 | |||||||||
2 | Y | 2 SOC Chemotherapy | 3 | 3 | 3 | 3 | 2 | 1 | 11/27/2023 | |||||
3 SOC Chemotherapy + Durvalumab | 3 | 3 | 3 | 3 | 2 | 1 | ||||||||
6 | 6 | 6 | 6 | 4 | 2 | |||||||||
S2212-Breast, TNBC, Neoadj Chemo + Pembro | 1 | Y | 1 Carbo + Paclitaxel + Pembro -> AC + Pembro | 2400 | 42 | 42 | 41 | 32 | 13 | 2 | 09/15/2023 | 260 | 109 | |
2 Carbo + Docetaxel + Pembro | 45 | 45 | 44 | 32 | 15 | 2 | ||||||||
87 | 87 | 85 | 64 | 28 | 4 | |||||||||
Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 41 | 20 | 8 | 2 | 0 | 0 | 03/11/2021 | 422 | 214 | |
41 | 20 | 8 | 2 | 0 | 0 | |||||||||
A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab | 1 | E | Total Registrations | 5 | 5 | 4 | 1 | 0 | 0 | 08/24/2023 | 290 | 138 | ||
5 | 5 | 4 | 1 | 0 | 0 | |||||||||
MA39-BREAST, Node-Pos, Reg RT vs No Reg RT | 1 | E | Total Registrations | 26 | 13 | 6 | 4 | 3 | 0 | 10/18/2019 | 367 | 140 | ||
26 | 13 | 6 | 4 | 3 | 0 | |||||||||
2 | E | Total Registrations | 25 | 12 | 5 | 3 | 2 | 0 | 10/18/2019 | |||||
25 | 12 | 5 | 3 | 2 | 0 | |||||||||
NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | 147 | 55 | ||
1 | 0 | 0 | 0 | 0 | 0 | |||||||||
NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | ||||
7 | 0 | 0 | 0 | 0 | 0 | |||||||||
No | NRGBR007-Breast, Stg I, De-Escalation of Breast RT | 1 | E | Total Registrations | 8 | 5 | 2 | 0 | 0 | 0 | 06/01/2022 | 345 | 154 | |
8 | 5 | 2 | 0 | 0 | 0 | |||||||||
2 | E | Total Registrations | 8 | 5 | 2 | 0 | 0 | 0 | 06/01/2022 | |||||
8 | 5 | 2 | 0 | 0 | 0 | |||||||||
NRGBR009-Breast, EarlyStg, Adjuvant Chemo | 1 | E | Total Registrations | 3 | 3 | 3 | 3 | 2 | 0 | 01/31/2024 | 99 | 38 | ||
3 | 3 | 3 | 3 | 2 | 0 | |||||||||
2 | E | Total Registrations | 3 | 3 | 3 | 3 | 2 | 0 | 01/31/2024 | |||||
3 | 3 | 3 | 3 | 2 | 0 | |||||||||